Oral anticoagulant therapy (OAT) is often necessary among arrhythmic hemodialysis (HD) patients.
AIM of the study: To evaluate heparin-free dialysis with the use of a citrate-enriched dialysate in patients under OAT.
METHODS
All patient under OAT were proposed the study. Each patient is its own-control. Table 1. 2-The visual score decreased during heparinfree dialysis but it was not significant.
3-Clotting events
were not statistically different between the three periods P1, P2 and P3 (respectively only 2, 2 and 4 circuit clotting episodes).
4-Ionized calcium (iCa) after dialysis
decreased significantly between P2 and P3 (mean of 1,22±0.081 vs 1,07±0.23 mmol/L p<0.0001) whereas there was no statistical difference for total calcium (Tca). Magnesium remained unchanged before and after dialysis at P1, P2 and P3.
5-Parathormone (PTH) assessed before dialysis increased significantly between P2 and P3 (191±137 to 257±155, p=0,008) .
CONCLUSIONS :
Heparin-free dialysis with CD can be used in dialysis among patients under OAT without higher risk of clotting events. It requires dialysate calcium adjustment to limit the fall of ionized calcium and the increase in PTH. If confirmed in a larger trial, this strategy could significantly reduce the high bleeding risk in HD patients requiring OAT.
